U.S. Federal Appeals Court Upholds $25m Monsanto Roundup Cancer Verdict
The Californer/10135523

SAN FRANCISCO, May 14, 2021 /PRNewswire/ -- A federal appellate ruling upholding findings that Bayer AG's Monsanto Roundup weed killer caused a California man's non-Hodgkins lymphoma cancer deals a blow to efforts by Bayer AG to push through a flawed settlement of thousands of pending cancer lawsuits, trial lawyers with Dallas-based Fears Nachawati Law Firm said Friday.

Fears Nachawati lawyers, who represent more than 4,000 cancer victims in litigation against Bayer AG (OTCMKTS: BAYRY), will discuss the significance of the ruling in Hardeman v. Monsanto and the status of the proposed settlement during a Facebook Live news conference on Monday at 11 a.m. Central. Click here for details: https://bit.ly/3bramVi

"This resounding victory for cancer victims could not have come at a worse time for Bayer as it tries to steamroll plaintiffs into accepting a flawed and unfair settlement," said Fears Nachawati co-founder Majed Nachawati. "Everyone now has a better understanding of the value of these cases and the exposure Bayer faces if it does not reach a fair settlement and resolve all outstanding lawsuits."

More on The Californer

• VCCCD Announces Ventura College Presidential Finalists
• Squeegex Expands Window Cleaning and Exterior Services Across 30+ San Diego Neighborhoods
• Long Beach: City Recognizes Tsunami Preparedness Week 2026: Know the Risk. Know the Route.
• Mark Dobosz Makes Donorassess.org Free To Every Nonprofit On The Planet
• THE DASH CAM: THINKWARE Launches Big Spring Sale on Select Dash Cam Models

Friday's ruling stems from a 2019 jury verdict finding that plaintiff Edwin Hardeman developed non-Hodgkins lymphoma after exposure to Roundup. The verdict included $5 million in compensatory damages and $75 million in punitive damages, which were later reduced to $20 million.

The ruling has implications for Bayer's efforts to settle more than 90,000 pending cancer lawsuits, which have drawn criticism from thousands of plaintiffs. Among other things, the settlement would allow Bayer to continue selling Roundup but limit legal options for individuals diagnosed with cancer in the future. A hearing on the settlement is set for May 19.

"We now have a federal appellate court supporting evidence that Roundup causes cancer and that Bayer had a duty to warn consumers," Mr. Nachawati said. "Shareholders need to know that these lawsuits will not stop until Bayer makes a meaningful settlement offer."

More on The Californer

• Genpak Announces Closure of Utah Manufacturing Facility
• Magai V3 Launches to Deliver a Faster, Cleaner, More Capable AI Workspace
• Newborn Care Network Introduces Clinical Standard to Bridge the Six-Week Postpartum Gap
• California: Governor Newsom announces nearly $900 million for cutting-edge transportation systems of the future
• United Hotel Supply Expands PIP Renovation & Wholesale Hotel Supply Services Across the USA

Dallas-based Fears | Nachawati Law Firm represents individuals in mass tort litigation, businesses and governmental entities in contingent litigation and individual victims in complex personal injury litigation. The largest and most diverse products liability law firm in the nation, Fears | Nachawati was ranked No. 1 nationally in product liability filings in federal court over the last three years. For more information, visit https://www.fnlawfirm.com.

Media Contact:
Robert Tharp
214-420-6011
[email protected]

SOURCE Fears Nachawati Law Firm

Related Links

https://www.fnlawfirm.com

---

Show All News | Report Violation